Genmab reports positive Phase 3 results for three cancer treatments
Genmab reported positive Phase 3 results for three cancer treatments.
Related stories
Amazon shares fall as AI spending outpaces cloud growth
Amazon’s fourth-quarter revenue outlook is reported against market expectations.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC
Quaker Chemical Reports Quarterly Results
Quaker Chemical reported results for the quarter ended September 30; the supplied text provides no figures.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC
PennyMac Mortgage Investment Trust Reports Quarterly Results
PennyMac Mortgage Investment Trust reports results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC
Alliant Energy Reports Quarterly Results for Period Ended Sept. 30
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC
AIA Expects Operating Profit Per Share Growth to Exceed Target
AIA expects annual operating profit per share growth to exceed its 9% to 11% target for 2023–2026.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC
Banco Macro Announces a Share Buyback
Banco Macro announced a buyback of its own shares.
M impact | EQUITY | Oct 29, 2026, 11:34 PM UTC